Steven Cohen’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,380
Closed -$5.4M – 4060
2026
Q2
$4.96M Buy
+23,380
New +$4.59M 0.01% 1766
2026
Q1
– Sell
-100,301
Closed -$17.4M – 3921
2025
Q4
$17.4M Buy
+100,301
New +$18.3M 0.02% 989
2024
Q3
– Sell
-299,740
Closed -$41M – 2061
2024
Q2
$41M Buy
299,740
+206,640
+222% +$28.3M 0.11% 249
2024
Q1
$12.4M Sell
93,100
-49,269
-35% -$6.39M 0.03% 640
2023
Q4
$19.6M Buy
+142,369
New +$18.7M 0.05% 434
2023
Q3
– Sell
-971,123
Closed -$129M – 2545
2023
Q2
$137M Buy
971,123
+678,163
+231% +$93.5M 0.41% 47
2023
Q1
$41.4M Sell
292,960
-238,238
-45% -$34.1M 0.13% 199
2022
Q4
$83.1M Buy
+531,198
New +$76.3M 0.28% 83
2022
Q3
– Sell
-42,659
Closed -$5.67M – 1465
2022
Q2
$5.67M Buy
+42,659
New +$5.81M 0.02% 669
2020
Q3
– Sell
-1,500
Closed -$171K – 963
2020
Q2
$171K Buy
+1,500
New +$159K ﹤0.01% 753
2019
Q1
– Sell
-150,000
Closed -$12.5M – 1059
2018
Q4
$12.5M Buy
+150,000
New +$14.1M 0.06% 364
2018
Q1
– Sell
-56,000
Closed -$5.52M – 974
2017
Q4
$5.52M Buy
+56,000
New +$5.31M 0.02% 573
2017
Q3
– Sell
-24,500
Closed -$2.72M – 910
2017
Q2
$2.72M Buy
+24,500
New +$2.59M 0.02% 605
2014
Q3
– Sell
-155,400
Closed -$9.12M – 672
2014
Q2
$9.12M Buy
+155,400
New +$9.1M 0.06% 339

Other funds holding DGX

Steven Cohen's DGX Position: Q3 2026 in Review

Steven Cohen sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 23,380 shares — an estimated $5.4M sold.

Steven Cohen first reported a position in DGX in Q2 2014 and held it in 14 quarters. The position peaked at $137M in Q2 2023. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Steven Cohen reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 23,380 Quest Diagnostics shares in Q3 2026, an estimated $5.4M.
  • Steven Cohen first reported a position in Quest Diagnostics in Q2 2014 and held it in 14 quarters.
  • Steven Cohen's Quest Diagnostics position peaked at $137M in Q2 2023.
  • 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.